In a cohort of limited-stage small cell lung cancer patients (LS-SCLC), CRT resulted in an increase of all T cells (CD3+), cytotoxic T cells (CD3+CD8+), activated T effector cells (CD8+CD38+) and NKT cells (28). Here, CD38 is linked to small cell lung carcinoma.